Survival rate in hypertensive patients with COVID-19.
Afagh MoattariFatemeh JavanmardiAli AkbariJavad KojuriHamid BakhtiariTahereh RezaeiAbdolkhalegh KeshavarziFarshad FalahatiPublished in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2020)
The current study about the survival rate of COVID-19 patients had shown hypertensive patents are in danger of disease severity, although it may be related to their age. Moreover, the probability of other complications like diabetes, smoking, asthma, kidney, and cardiovascular diseases, and either some other infections such as HIV can make the condition complicated and need more consideration to prevent noxious outcomes.
Keyphrases
- cardiovascular disease
- blood pressure
- type diabetes
- antiretroviral therapy
- hiv positive
- hiv infected
- chronic obstructive pulmonary disease
- sars cov
- human immunodeficiency virus
- free survival
- glycemic control
- hepatitis c virus
- lung function
- hiv aids
- hiv testing
- smoking cessation
- risk factors
- coronary artery disease
- metabolic syndrome
- cystic fibrosis
- cardiovascular events
- allergic rhinitis
- air pollution
- insulin resistance
- skeletal muscle